Abstract
Somatostatin, a neuropeptide with multiple activities, exerts its function via G-coupled membrane receptors. Five somatostatin receptor subtypes, sst1–5, have been identified. We have recently established that somatostatin acts as a chemoattractant on normal hematopoietic progenitor cells. Here, we studied the expression of somatostatin receptors (sst) on leukemic cells from 16 AML patients. Using fluorescent somatostatin (Fluo-SS) in flow cytometry, we found that sst are expressed in variable amounts on primary AML cells. Reverse transcriptase polymerase chain reaction (RT-PCR) analysis and immunochemistry revealed that only sst subtype 2 is expressed by AML cells. Using a two-chamber in vitro migration assay, we show that AML cells migrated towards a gradient of octreotide, a stable synthetic analogue of somatostatin. The degree of migration correlated with the cell surface density of sst2 as measured by Fluo-SS binding. These findings indicate that somatostatin influences trafficking of AML cells, which may have implications for the distribution of AML cells in the body and for clinical applications of somatostatin and analogues thereof in the context of AML.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reichlin S . Somatostatin N Engl J Med 1983 309: 1495–1501
Schonbrunn A, Tashjian H Jr . Characterization of functional receptors for somatostatin in rat pituitary cells in culture J Biol Chem 1978 253: 6473–6483
Reisine T, Bell GI . Molecular biology of somatostatin receptors Endocr Rev 1995 16: 427–442
Patel YC . Molecular pharmacology of somatostatin receptor subtypes J Endocrinol Invest 1997 20: 348–367
Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB . The somatostatin receptor family Life Sci 1995 57: 1249–1265
Patel YC . Somatostatin and its receptor family Front Neuroendocrinol 1999 20: 157–198
Vanhagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Lowenberg B, Lamberts SW . Somatostatin analogue scintigraphy of malignant lymphomas Br J Haematol 1993 83: 75–79
Vanhagen PM, Markusse HM, Lamberts SW, Kwekkeboom DJ, Reubi JC, Krenning EP . Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis Arthritis Rheum 1994 37: 1521–1527
Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogstede HC, Lamberts SW . Somatostatin analogue scintigraphy in granulomatous diseases Eur J Nucl Med 1994 21: 497–502
ten Bokum AM, Melief MJ, Schonbrunn A, van der Ham F, Lindeman J, Hofland LJ, Lamberts SW, van Hagen PM . Immunohistochemical localization of somatostatin receptor sst2A in human rheumatoid synovium J Rheumatol 1999 26: 532–535
ten Bokum AM, Hofland LJ, de Jong G, Bouma J, Melief MJ, Kwekkeboom DJ, Schonbrunn A, Mooy CM, Laman JD, Lamberts SW, van Hagen PM . Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas Eur J Clin Invest 1999 29: 630–636
Reubi JC, Horisberger U, Waser B, Gebbers JO, Laissue J . Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue Gastroenterology 1992 103: 1207–1214
Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SW, Gebbers JO, Gersbach P, Laissue JA . In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue Blood 1993 82: 2143–2151
Reubi JC, Horisberger U, Kappeler A, Laissue JA . Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs Blood 1998 92: 191–197
Reubi JC, Waser B, van Hagen M, Lamberts SW, Krenning EP, Gebbers JO, Laissue JA . In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas Int J Cancer 1992 50: 895–900
Santini V, Lamberts SW, Krenning EP, Backx B, Lowenberg B . Somatostatin and its cyclic octapeptide analog SMS 201–995 as inhibitors of proliferation of human acute lymphoblastic and acute myeloid leukemia Leukemia Res 1995 19: 707–712
Hiruma K, Koike T, Nakamura H, Sumida T, Maeda T, Tomioka H, Yoshida S, Fujita T . Somatostatin receptors on human lymphocytes and leukaemia cells Immunology 1990 71: 480–485
Bot FJ, Dorssers L, Wagemaker G, Lowenberg B . Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessory cells Blood 1988 71: 1609–1614
Delwel R, Dorssers L, Touw I, Wagemaker G, Lowenberg B . Human recombinant multilineage colony stimulating factor (interleukin- 3): stimulator of acute myelocytic leukemia progenitor cells in vitro Blood 1987 70: 333–336
Ferone D, van Hagen PM, van Koetsveld PM, Zuijderwijk J, Mooy DM, Lichtenauer-Kaligis EG, Colao A, Bogers AJ, Lombardi G, Lamberts SW, Hofland LJ . In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells Endocrinology 1999 140: 373–380
Hofland LJ, Liu Q, Van Koetsveld PM, Zuijderwijk J, Van Der Ham F, De Krijger RR, Schonbrunn A, Lamberts SW . Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors J Clin Endocrinol Metab 1999 84: 775–780
Voermans C, Gerritsen WR, von dem Borne AE, van der Schoot CE . Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters Exp Hematol 1999 27: 1806–1814
Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC . The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood J Exp Med 1997 185: 111–120
Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L . The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1 Blood 1998 91: 4523–4530
Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA . Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta J Clin Endocrinol Metab 1993 77: 1323–1328
Lamberts SW, Krenning EP, Reubi JC . The role of somatostatin and its analogs in the diagnosis and treatment of tumors Endocr Rev 1991 12: 450–482
Lamberts SW . The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors Endocr Rev 1988 9: 417–436
Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE . Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial J Clin Oncol 1995 13: 2012–2015
Wulfsen I, Meyerhof W, Fehr S, Richter D . Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary J Neurochem 1993 61: 1549–1552
Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y . Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201–995 in treatment of human endocrine tumors J Clin Invest 1994 93: 1321–1325
Acknowledgements
We thank Dr Alister C Ward and Dr Mirjam HA Hermans for critical reading of the manuscript and Dr A Schonbrunn for providing the R2–88 antibody. This work was supported by funds from the Nederlandse Wetenschappelijke Organisatie (NWO), and grants from the Dutch Cancer Society.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oomen, S., Lichtenauer-Kaligis, E., Verplanke, N. et al. Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2. Leukemia 15, 621–627 (2001). https://doi.org/10.1038/sj.leu.2402061
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402061
Keywords
This article is cited by
-
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment
Pharmaceutical Research (2020)
-
GScluster: network-weighted gene-set clustering analysis
BMC Genomics (2019)